SPY345.78+1.17 0.34%
DIA283.34-0.31 -0.11%
IXIC11,548.28+42.28 0.37%

Aligos Therapeutics Priced 10M Share IPO @$15/Share

Aligos Therapeutics, Inc. (NASDAQ: ALGS) announced the pricing of its initial public offering of 10,000,000 shares of its common stock at a public offering price of $15.00 per share.

· 10/16/2020 05:46
Aligos Therapeutics, Inc. (NASDAQ:ALGS) announced the pricing of its initial public offering of 10,000,000 shares of its common stock at a public offering price of $15.00 per share. In addition, Aligos has granted the underwriters a 30-day option to purchase up to an additional 1,500,000 shares of common stock at the initial public offering price. The gross proceeds from the offering, before deducting underwriting discounts and commissions and other offering expenses payable by Aligos, are expected to be approximately $150.0 million, excluding any exercise of the underwriters' option to purchase additional shares. Aligos' common stock is expected to begin trading on the Nasdaq Global Select Market on October 16, 2020, under the ticker symbol "ALGS." The offering is expected to close on October 20, 2020, subject to customary closing conditions. J.P. Morgan, Jefferies and Piper Sandler are acting as the joint book-running managers for the offering. Cantor is acting as a lead manager for the offering.